Expression of GnRH type II is regulated by the androgen receptor in prostate cancer

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 613-624

  Darby, S ^a   Stockley, J ^a   Khan, M M ^b   Robson, C N ^a   Leung, H Y ^a   Gnanapragasam, V J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; CYCLOHEXIMIDE; GONADORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE; GNRH 2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR BIOPSY; XENOGRAFT;

ANDROGENS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 35949003275     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0041     Document Type: Article

References (45)

1. An BS, Choi JH, Choi KC & Leung PC 2005 Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II. Journal of Clinical Endocrinology and Metabolism 90 1106-1113.
2. Belsham DD, Evangelou A, Roy D, Due VL & Brown TJ 1998 Regulation of gonadotropin-releasing hormone (GnRH) gene expression by 5α- dihydrotestosterone in GnRH-secreting GT1-7 hypothalamic neurons. Endocrinology 139 1108-1114.
3. Chen A, Laskar-Levy O, Ben-Aroya N & Koch Y 2001 Transcriptional regulation of the human GnRH II gene is mediated by a putative cAMP response element. Endocrinology 142 3483-3492.
4. Chen A, Zi K, Laskar-Levy O & Koch Y 2002a The transcription of the hGnRH-I and hGnRH-II genes in human neuronal cells is differentially regulated by estrogen. Journal of Molecular Neuroscience 18 67-76.
5. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E & Koch Y 2002b Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Research 62 1036-1044.
6. Cheng CK, Hoo RL, Chow BK & Leung PC 2003 Functional cooperation between multiple regulatory elements in the un-translated exon 1 stimulates the basal transcription of the human GnRH-II gene. Molecular Endocrinology 17 1175-1191.
7. Choi KC, Auersperg N & Leung PC 2001 Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. Journal of Clinical Endocrinology and Metabolism 86 5075-5078.
8. Choi JH, Choi KC, Auersperg N & Leung PC 2006 Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells. Endocrine-Related Cancer 13 641-651.
9. Cronauer MV, Schulz WA, Burchardt T, Anastasiadis AG, de la Taille A, Ackermann R & Burchardt M 2003 The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signalling. International Journal of Oncology 23 1095-1102.
10. Dondi D, Moretti RM, Montagnani Marelli M, Pratesi G, Polizzi D, Milani M, Motta M & Limonta P 1998 Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice. International Journal of Cancer 76 506-511.
11. Eicke N, Gunthert AR, Viereck V, Siebold D, Behe M & Becker T 2005 GnRH-II receptor-like antigenicity in human placenta and in cancers of the human reproductive organs. European Journal of Endocrinology 153 605-612.
12. Gaughan L, Logan IR, Cook S, Neal DE & Robson CN 2002 Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. Journal of Biological Chemistry 277 25904-25913.
13. Gnanapragasam VJ, Robson CN, Neal DE & Leung HY 2002 Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21 5069-5080.
14. Gnanapragasam VJ, Darby S, Khan MM, Lock WG, Robson CN & Leung HY 2005 Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer. Journal of Pathology 206 205-213.
15. Grossmann ME, Huang H & Tindall DJ 2001 Androgen receptor signalling in androgen-refractory prostate cancer. Journal of the National Cancer Institute 93 1687-1697.
16. Grundker C, Gunthert AR, Millar RP & Emons G 2002 Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. Journal of Clinical Endocrinology and Metabolism 87 1427-1430.
17. Grundker C, Schlotawa L, Viereck V, Eicke N, Horst A, Kairies B & Emons G 2004 Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. European Journal of Endocrinology 151 141-149.
18. Gunthert AR, Grundker C, Olota A, Lasche J, Eicke N & Emons G 2005 Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen. European Journal of Endocrinology 153 613-625.
19. Halkidou K, Gnanapragasam VJ, Mehta PB, Logan IR, Brady ME, Cook S, Leung HY, Neal DE & Robson CN 2003 Expression of Tip60, an androgen receptor co-activator, and its role in prostate cancer development. Oncogene 22 2466-2477.
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA & Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Research 43 4809-4818.
21. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C & Thun MJ 2006 Cancer statistics 2006. CA: A Cancer Journal for Clinicians 56 106-130.
22. Kang SK, Tai CJ, Nathwani PS & Leung PC 2001 Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 142 182-192.
23. Khosravi S & Leung PC 2003 Differential regulation of gonadotropin-releasing hormone (GnRH) I and GnRH II messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells. Journal of Clinical Endocrinology and Metabolism 88 663-672.
24. Kim D, Gregory CW, French FS, Smith GJ & Mohler JL 2002 Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. American Journal of Pathology 160 219-226.
25. Kim KY, Choi KC, Park SH, Chou CS, Auersperg N & Leung PC 2004 Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells. Journal of Clinical Endocrinology and Metabolism 89 3020-3026.
26. Kim KY, Choi KC, Park SH, Auersperg N & Leung PC 2005 Extracellular signal-regulated protein kinase, but not N-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation. Journal of Clinical Endocrinology and Metabolism 90 1670-1677.
27. Kim KY, Choi KC, Auersperg N & Leung PC 2006 Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Endocrine-Related Cancer 13 211-220.
28. Limonta P, Moretti RM, Marelli MM, Dondi D, Parenti M & Motta M 1999 The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway. Endocrinology 140 5250-5256.
29. Ling MT, Chan KW & Choo CK 2001 Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line. Journal of Endocrinology 170 287-296.
30. Litvinov AntonyL IV, Dalrymple SL, Becker R, Cheng L & Isaacs JT 2006 PC3, but not DU145, human prostate cancer cells retain the co-regulators required for tumour suppressor ability of androgen receptor. Prostate 66 1329-1338.
31. Lu ZL, Gallagher R, Sellar R, Coetsee M & Millar RP 2005 Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations. Journal of Biological Chemistry 280 29796-29803.
32. Maiti K, Oh DY, Moon JS, Acharjee S, Li JH & Bai DG 2005 Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signalling and death. Journal of Clinical Endocrinology and Metabolism 90 4287-4298.
33. Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Carvalho R & Lopes C 2002 Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumour cells. Prostate 53 88-94.
34. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K & Maudsley SR 2004 Gonadotropin-releasing hormone receptors. Endocrine Reviews 25 235-275.
35. Nathwani PS, Kang SK, Cheng KW, Choi KC & Leung PC 2000 Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17β-estradiol in cultured human granulosa-luteal cells. Endocrinology 141 1754-1763.
36. Neill JD 2002 GnRH and GnRH receptor genes in the human genome. Endocrinology 143 737-743.
37. Neill JD, Musgrove LC & Duck LW 2004 Newly recognized GnRH receptors: function and relative role. Trends in Endocrinology and Metabolism 15 383-392.
38. Roche PJ, Hoare SA & Parker MG 1992 A consensus DNA-binding site for the androgen receptor. Molecular Endocrinology 6 2229-2235.
39. Rossi R, Zatelli MC, Franceschetti P, Maestri I, Magri E, Aguiari G, Cavazzini P, Uberti EC EC & del Senno L 1996 Inhibitory effect of dihydrotestosterone on human thyroid cell growth. Journal of Endocrinology 151 185-194.
40. Rossi R, Zatelli MC, Valentini A, Cavazzini P, Fallo F, del Senno L & degli Uberti EC 1998 Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells. Journal of Endocrinology 159 373-380.
41. Temple JL, Millar RP & Rissman EF 2003 An evolutionarily conserved form of gonadotropin-releasing hormone coordinates energy and reproductive behavior. Endocrinology 144 13-19.
42. Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Pretlow TP, Bodner DR & Kursh ED 1994 CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Research 54 6049-6052.
43. Wang Q, Carroll JS & Brown M 2005 Spatial and temporal recruitment of androgen receptor and its co-activators involves chromosomal looping and polymerase tracking. Molecular Cell 19 631-642.
44. Whitacre DC, Chauhan S, Davis T, Gordon D, Cress AE & Miesfeld RL 2002 Androgen induction of in vitro prostate cell differentiation. Cell Growth and Differentiation 13 1-11.
45. White RB, Eisen JA, Kasten TL & Fernald RD 1998 Second gene for gonadotropin-releasing hormone in humans. PNAS 95 305-309.